When was Molecular Instruments founded?

Molecular Instruments was founded in 2018 and raised its 1st funding round 3 years after it was founded.

Where is Molecular Instruments located?

Molecular Instruments is headquartered in Los Angeles, United States.

Who is the current CEO of Molecular Instruments?

Harry M T Choi of Molecular Instruments.

How many employees does Molecular Instruments have?

As of Aug 31, 2026, the latest employee count at Molecular Instruments is 30.

Is Molecular Instruments a funded company?

Molecular Instruments is a funded company, having raised an undisclosed amount across 4 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on Apr 01, 2021.

When was the latest funding round of Molecular Instruments?

Molecular Instruments' latest funding was a $***** Grant (prize money) round on Aug 25, 2025, with participation from 1 investor.

Where does Molecular Instruments rank among its competitors?

Molecular Instruments ranks 49th amongst 891 active competitors, of which 130 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Techcyte, which secured $15M in Apr, 2026.

Who are the top competitors of Molecular Instruments?

Molecular Instruments' top competitors include Strand Life Sciences, PathAI and Deciphex. Among them, Techcyte secured the most recent funding round in April, 2026.

Molecular Instruments - 2026 Company Profile, Team, Funding & Competitors

Molecular Instruments is a funded company based in Los Angeles (United States), founded in 2018 by Harry M T Choi and Niles A Pierce. It operates as a Provider and developer of molecular instruments for drug development. Molecular Instruments has raised an undisclosed amount in funding. The company has 891 active competitors, including 130 funded and 81 that have exited. Its top competitors include companies like Strand Life Sciences, PathAI and Deciphex.

Company Details

Provider and developer of molecular instruments for drug development. The company has designed a molecular hybridization instrument that assists academic researchers with, drug development and clinical diagnosis. The device has features for a hybridization chain reaction, qHCR Imaging, flow cytometry, northern blots, and more.

Website: www.molecularinstruments.com/
Social
Email ID: *****@molecularinstruments.com
Phone Number: +1 **********

Key Metrics

Founded Year

2018

Location

Los Angeles, United States

Stage

Funding Raised

Latest Funding Round

Grant (prize money), Aug 25, 2025, $*****

Investors

HHS

Ranked

49^th among 891 active competitors

Employee Count

30 as on Aug 31, 2026

Similar Companies

Strand Life Sciences & 1040 more

View Molecular Instruments' full profile

Molecular Instruments has raised funding over 4 rounds. Its first funding round was on Apr 01, 2021. Its latest funding round was a Grant (prize money) round on Aug 25, 2025 for $*****. 1 investor participated in its latest round. Molecular Instruments has 1 institutional investor.

Here is the list of recent funding rounds of Molecular Instruments:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Aug 25, 2025	8570090	Grant (prize money)	4730101	5270081	8453031	5560462
Jul 01, 2025	1672619	Grant (prize money)	6398941	6625710	7355897	HHS
Sep 01, 2024	9186962	Grant (prize money)	5775878	8328806	5708800	HHS

Access funding benchmarks and valuations. Sign up today!

View details of Molecular Instruments's funding rounds and investors

The founders of Molecular Instruments are Harry M T Choi and Niles A Pierce.

Here are the details of Molecular Instruments' key team members:

Harry M T Choi: Founder & CEO of Molecular Instruments.
Contact Info: 1 email address
Niles A Pierce: Founder of Molecular Instruments.
Contact Info: 1 email address

View details of Molecular Instruments's Founder profiles and Board Members

Molecular Instruments' employee count trend

Molecular Instruments has 30 employees as of Aug 26. Here is Molecular Instruments's employee count trend over the years:

Employee count trend for Molecular Instruments

Uncover Molecular Instruments' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Molecular Instruments include Strand Life Sciences, PathAI and Deciphex. Here is the list of Top 10 competitors of Molecular Instruments, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Strand Life Sciences 2000, Bengaluru (India), Acquired	Provider of omics-based solutions for clinical genomics, systems biology, and drug discovery	$34.9M	Biomark Capital, WestBridge Capital & 92 others	74/100
2nd	PathAI 2016, Boston (United States), Series C	Provider of digital pathology image management system for clinical labs	$255M	General Catalyst, General Atlantic & 22 others	70/100
3rd	Deciphex 2017, Dublin (Ireland), Series C	Network of pathologists providing digital diagnostic services for medical testing	$56.6M	Seroba Life Sciences, Molten Ventures & 13 others	65/100
4th	Aiforia 2014, Helsinki (Finland), Public	Provider of an AI and cloud-based, deep learning image analysis platform in all therapy areas	$23M	Ascend Capital Partners, Businessfinland & 8 others	64/100
5th	BGI 1999, Shenzhen (China), Public	Provider of services in genome sequencing	-	Sequoia Capital China, Yunfeng Capital & 15 others	64/100
6th	Aignostics 2018, Berlin (Germany), Series B	Developer of artificial intelligence software for biomedical image analysis applications	$53.9M	Wellington Partners Venture Capital, Boehringer Ingelheim Venture Fund ... & 9 others	64/100
7th	Nucle AI 2017, Chicago (United States), Series B	AI-assisted platform for image analysis	$60M	Vertex Ventures Israel, Sanofi Ventures & 9 others	62/100
8th	Techcyte 2014, Orem (United States), Series B	Artificial intelligence (AI) based image analysis platform for pathologists	$50.4M	ARUP Laboratories, Zoetis & 2 others	62/100
9th	Visiopharm 2001, Horsholm (Denmark), Acquired	Developer of a SaaS and AI-based digital pathology solutions for image analysis and workflow standardization	$26.3M	BankInvest, Vaekstfonden & 4 others	60/100
10th	HistoIndex 2010, Singapore (Singapore), Series A	Provider of AI powered digital pathology platform for fibrosis analysis	$6.89M	OCBC, SEEDS Capital & 2 others	57/100
49th	Molecular Instruments 2018, Los Angeles (United States), Funding Raised	Provider and developer of molecular instruments for drug development	-	HHS	43/100

Get insights and benchmarks for competitors of 2M+ companies! Sign up today!

Looking for more details on Molecular Instruments's competitors? Click here to see the top ones

Molecular Instruments has made no investments or acquisitions yet.

Here is the latest report on Molecular Instruments's sector:

Free

Internet of Things - Sector Report

Edition: August, 2026 (80 Pages)

View all reports related to Molecular Instruments

Media has covered Molecular Instruments for a total of 3 events in the last 1 year, 2 of them have been about company updates and 1 about partnerships.